Last reviewed · How we verify
Vitamin A + Zinc — Competitive Intelligence Brief
marketed
Micronutrient supplement combination
Immunology / Infectious Disease
Small molecule
Live · refreshed every 30 min
Target snapshot
Vitamin A + Zinc (Vitamin A + Zinc) — National Institute of Allergy and Infectious Diseases (NIAID). Vitamin A and zinc work synergistically to support immune function and mucosal barrier integrity, enhancing resistance to infections.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Vitamin A + Zinc TARGET | Vitamin A + Zinc | National Institute of Allergy and Infectious Diseases (NIAID) | marketed | Micronutrient supplement combination |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Micronutrient supplement combination class)
- National Institute of Allergy and Infectious Diseases (NIAID) · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Vitamin A + Zinc CI watch — RSS
- Vitamin A + Zinc CI watch — Atom
- Vitamin A + Zinc CI watch — JSON
- Vitamin A + Zinc alone — RSS
- Whole Micronutrient supplement combination class — RSS
Cite this brief
Drug Landscape (2026). Vitamin A + Zinc — Competitive Intelligence Brief. https://druglandscape.com/ci/vitamin-a-zinc. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab